surpass 3 tirzepatide Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the Clinical Trial Program | Cardiovascular Diabetology LLY says #semaglutide Sustain-1 $NVO

These drugs, widely used for weight loss, mimic a natural hormone in the body to help regulate appetite, slow digestion, and, for some people especially those living with type 2 diabetes lower blood glucose levels

Semaglutide competes strongly against oral weight-loss medications which are generally less expensive but less effective

doi: 10.3389/fnut.2025.1659233 Received 03 July 2025 Accepted 18 August 2025 Published 11 September 2025 Volume 12 - 2025 Edited by Phiwayinkosi V

Its best to consult with a healthcare provider to determine which medication may be the most suitable for your specific needs and health goals